Diseases, Conditions, Syndromes

TB drug price slashed in global push to thwart killer disease

A pharmaceutical multinational on Thursday slashed the price of a key anti-tuberculosis drug boosting the battle against the world's deadliest infectious disease, as a new treatment was also set to begin extensive testing.

Diseases, Conditions, Syndromes

Tuberculous infection is not life-long in most people

A new analysis challenges the longstanding notion that tuberculous infection is a life-long infection that could strike at any time and cause tuberculosis (TB). Based on a review of clinical studies, researchers from the ...

Diseases, Conditions, Syndromes

Australian trial halves number of tuberculosis cases

Annual community-wide screening for tuberculosis almost halves the number of cases of the deadly disease, a four-year study by Australian and Vietnamese researchers has found.

Diseases, Conditions, Syndromes

12.6 million in U.S. could benefit from therapy to prevent active TB

(HealthDay)—An estimated 12.6 million persons in the United States could benefit from treatment to prevent active tuberculosis (TB), according to a report published in the October issue of Emerging Infectious Diseases, ...

page 28 from 40